Diversified Consumer Services
Company Overview of The Scripps Research Institute
The Scripps Research Institute is an educational institution that offers graduate programs and postdoctoral fellows in biological and chemical sciences. It also provides programs for high school and middle school students, teachers, and undergraduates. The institution was formerly known as Scripps Institutions of Medicine and Science. The Scripps Research Institute was founded in 1991 and is based in La Jolla, California.
10550 North Torrey Pines Road
La Jolla, CA 92037
Founded in 1991
Key Executives for The Scripps Research Institute
Executive Vice President and Chief Scientific Officer
Senior Vice President, Chief Financial Officer, and Treasurer
Professor and Director of Neurological Research Center
Senior Director of Business Development
Compensation as of Fiscal Year 2016.
The Scripps Research Institute Key Developments
The Scripps Research Institute Signs Collaboration Agreement with Pfizer to Advance DNA-Encoded Library Technology
Jan 10 17
The Scripps Research Institute announced a research collaboration and license agreement with Pfizer Inc. to pioneer new DNA-encoded library technology, including new synthetic chemistry for the creation of next-generation DELs, a potentially transformative technology for early stage drug discovery research. Under the terms of the collaboration, Pfizer will pay a technology access fee and thereby gain access to innovative chemical synthesis technology developed at TSRI. Members of the TSRI chemistry department—Professors Phil Baran, Ph.D., Dale Boger, Ph.D., Jin-Quan Yu, Ph.D., K. Barry Sharpless, Ph.D., and others—will work alongside Pfizer scientists to adapt these chemical methods for use in creating DELs, which require stringent processes that are tolerant of the delicate DNA backbone. TSRI and Pfizer may choose to expand the scope of the joint research to include other technologies relevant for enabling DEL-based drug discovery.
BlinkBio Inc. Announces Exclusive Agreement with The Scripps Research Institute Providing Targeting Technology for Use in BlinkBio’s Tunable Drug Conjugates Platform
Nov 10 16
BlinkBio Inc. announced the signing of an exclusive option agreement to license Dual Variable Domain-Fab (DVD-Fab) technology developed in the laboratories of Dr. Christoph Rader and Dr. William R. Roush at The Scripps Research Institute (TSRI) in Jupiter, FL. The technology comprises engineered antibody fragments that include regions of antibodies that recognize target proteins they are designed to bind, together with elements that allow the DVD-Fabs to connect to BlinkBio’s proprietary TDCs.
Yisheng Biopharma Announces Research Collaboration with The Scripps Research Institute in Developing New AIDS Vaccine
Nov 7 16
Yisheng Biopharma Co. Ltd. announced that it has entered into a collaboration with The Scripps Research Institute (TSRI) to test a new generation of AIDS vaccine based on novel gp140 trimers and self-assembling nanoparticles designed by TSRI scientists and Toll-Like Receptor 3 (TLR3) agonist adjuvant technology ("PIKA") developed by the company. The cooperative research partnership represents a new opportunity for both organizations to create more effective and safe vaccine products against HIV infection. Under the terms of the agreement, the scientists at TSRI will evaluate the potential of PIKA adjuvant for AIDS vaccine candidates. The PIKA adjuvant is a proprietary technology developed by Yisheng Biopharma, named as part of "National Key Medicine Innovation" in 2013 by the National Ministry of Science and Technology of China. Most recently Yisheng completed Phase II and Phase I clinical studies of PIKA based rabies and hepatitis B vaccines, respectively, which exhibited promising efficacy and safety in human subjects.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking
Most Searched Private Companies
Sponsored Financial Commentaries